Professor | Qing Jin | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Qing Jin
Contact Information	jinqing@hrbmu.edu.cn
Language ability	Chinese, English
Province	Heilongjiang

Upload Avatar (500 x 500)

Name

Qing Jin

Contact Information

jinqing@hrbmu.edu.cn

Language ability

Chinese, English

Province

Heilongjiang

University/Lab Affiliation and Title	Harbin Medical University
Faculty	College of Bioinformatics Science and Technology
Academic Background & Achievements	2018-09 to 2021-06 Doctorate: Harbin Medical University, Human Anatomy and Embryology 2015-09 to 2018-06 Master's: Harbin Medical University, Biomedical Engineering 2010-09 to 2015-06 Bachelor's: Harbin Medical University, Bioinformatics Published 14 SCI research papers, 4 as first or co-first author Led a postdoctoral project funded by Heilongjiang Province
Work Experience	2021-09 to 2023-09 - Harbin Medical University - Postdoctoral Researcher in Public Health and Preventive Medicine

University/Lab Affiliation and Title

Harbin Medical University

Faculty

College of Bioinformatics Science and Technology

Academic Background & Achievements

2018-09 to 2021-06 Doctorate: Harbin Medical University, Human Anatomy and Embryology
2015-09 to 2018-06 Master's: Harbin Medical University, Biomedical Engineering
2010-09 to 2015-06 Bachelor's: Harbin Medical University, Bioinformatics
Published 14 SCI research papers, 4 as first or co-first author
Led a postdoctoral project funded by Heilongjiang Province

Work Experience

2021-09 to 2023-09 - Harbin Medical University - Postdoctoral Researcher in Public Health and Preventive Medicine

Areas of Focus	AI-assisted drug development Personalized medicine
Publications	Predicting drug synergy using a network propagation inspired machine learning framework, Jin Q, Zhang X, Huo D, Xie H, Zhang D, Liu L, Zhao Y, Chen X, 2024 Network propagation-based identification of oligometastatic biomarkers in metastatic colorectal cancer, Qing Jin; Kexin Yu; Xianze Zhang; Diwei Huo; Denan Zhang; Lei Liu; Hongbo Xie; Binhua Liang; Xiujie Chen, 2023 Identification of Risk Molecular Subtype of Colon Cancer with Lymphovascular Invasion, Qing Jin; Binhua Liang; Xiujie Chen; Huiwen Liu, 2021 Large-Scale Analysis of Drug Side Effects via Complex Regulatory Modules Composed of microRNAs, Transcription Factors and Gene Sets, Qing Jin; Xiangqiong Liu; Xiusen Bian; Yunfeng Wang; Lei Liu; Hongzhe Ma; Fujian Tan; Mingliang Gu; Xiujie Chen, 2017 Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis, Lei Liu; Zhuo Shao; Jiaxuan Lv; Fei Xu; Sibo Ren; Qing Jin; Jingbo Yang; Weifang Ma; Hongbo Xie; Denan Zhang; Xiujie Chen, 2020 Biological evaluation and energetic analyses of novel GSK-3β inhibitors, Zhang D, Liu L, Pang L, Jin Q, Ke K, Hu M, Yang J, Ma W, Xie H, Chen X, 2018 CHG: A Systematically Integrated Database of Cancer Hallmark Genes, Zhang D, Huo D, Xie H, Wu L, Zhang J, Liu L, Jin Q, Chen X, 2020 A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data, Wang Y, Su Y, Zhao K, Huo D, Du Z, Wang Z, Xie H, Liu L, Jin Q, Ren X, Chen X, Zhang D, 2024 Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction, Cheng J, Xiao M, Meng Q, Zhang M, Zhang D, Liu L, Jin Q, Fu Z, Li Y, Chen X, Xie H, 2024 Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network, Liu L, Chen X, Hu C, Zhang D, Shao Z, Jin Q, Yang J, Xie H, Liu B, Hu M, Ke K, 2018 Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins, Xie H, Zeng D, Chen X, Huo D, Liu L, Zhang D, Jin Q, Ke K, Hu M, 2017 Identification of breast cancer recurrence risk factors based on functional pathways in tumor and normal tissues, Chen X, Liu L, Wang Y, Liu B, Zeng D, Jin Q, Li M, Zhang D, Liu Q, Xie H, 2017 Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study, Xie H, Wen H, Zhang D, Liu L, Liu B, Liu Q, Jin Q, Ke K, Hu M, Chen X, 2017 IGSA: Individual Gene Sets Analysis, including Enrichment and Clustering, Wu L, Chen X, Zhang D, Zhang W, Liu L, Ma H, Yang J, Xie H, Liu B, Jin Q, 2016

Areas of Focus

AI-assisted drug development
Personalized medicine

Publications

Predicting drug synergy using a network propagation inspired machine learning framework, Jin Q, Zhang X, Huo D, Xie H, Zhang D, Liu L, Zhao Y, Chen X, 2024
Network propagation-based identification of oligometastatic biomarkers in metastatic colorectal cancer, Qing Jin; Kexin Yu; Xianze Zhang; Diwei Huo; Denan Zhang; Lei Liu; Hongbo Xie; Binhua Liang; Xiujie Chen, 2023
Identification of Risk Molecular Subtype of Colon Cancer with Lymphovascular Invasion, Qing Jin; Binhua Liang; Xiujie Chen; Huiwen Liu, 2021
Large-Scale Analysis of Drug Side Effects via Complex Regulatory Modules Composed of microRNAs, Transcription Factors and Gene Sets, Qing Jin; Xiangqiong Liu; Xiusen Bian; Yunfeng Wang; Lei Liu; Hongzhe Ma; Fujian Tan; Mingliang Gu; Xiujie Chen, 2017
Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis, Lei Liu; Zhuo Shao; Jiaxuan Lv; Fei Xu; Sibo Ren; Qing Jin; Jingbo Yang; Weifang Ma; Hongbo Xie; Denan Zhang; Xiujie Chen, 2020
Biological evaluation and energetic analyses of novel GSK-3β inhibitors, Zhang D, Liu L, Pang L, Jin Q, Ke K, Hu M, Yang J, Ma W, Xie H, Chen X, 2018
CHG: A Systematically Integrated Database of Cancer Hallmark Genes, Zhang D, Huo D, Xie H, Wu L, Zhang J, Liu L, Jin Q, Chen X, 2020
A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data, Wang Y, Su Y, Zhao K, Huo D, Du Z, Wang Z, Xie H, Liu L, Jin Q, Ren X, Chen X, Zhang D, 2024
Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction, Cheng J, Xiao M, Meng Q, Zhang M, Zhang D, Liu L, Jin Q, Fu Z, Li Y, Chen X, Xie H, 2024
Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network, Liu L, Chen X, Hu C, Zhang D, Shao Z, Jin Q, Yang J, Xie H, Liu B, Hu M, Ke K, 2018
Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins, Xie H, Zeng D, Chen X, Huo D, Liu L, Zhang D, Jin Q, Ke K, Hu M, 2017
Identification of breast cancer recurrence risk factors based on functional pathways in tumor and normal tissues, Chen X, Liu L, Wang Y, Liu B, Zeng D, Jin Q, Li M, Zhang D, Liu Q, Xie H, 2017
Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study, Xie H, Wen H, Zhang D, Liu L, Liu B, Liu Q, Jin Q, Ke K, Hu M, Chen X, 2017
IGSA: Individual Gene Sets Analysis, including Enrichment and Clustering, Wu L, Chen X, Zhang D, Zhang W, Liu L, Ma H, Yang J, Xie H, Liu B, Jin Q, 2016

Artificial Intelligence Drug Development Machine Learning Bioinformatics Pharmacogenomics Personalized Medicine Data Analysis Genomics Healthcare Innovation

Hongying Zhao - Harbin Medical University

Hongbo Xie - Harbin Medical University

Li Xia - Harbin Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us